Viruses aren't just disease agents any more. Scientists now know they can be used in therapies for cancer but concerns over the safety of 'oncolytic viruses' remain because they can also damage healthy tissues.
But Mayo Clinic researchers say they have discovered a way of controlling the viruses behind potential cancer therapeutics by engineering the virus's genetic sequence, using microRNAs to restrict them to specific tissues. The microRNAs destabilize the virus's genome, making it impossible for the virus to run amok. The discovery is reported in the current issue of Nature Medicine.
MicroRNAs are the nucleotide snippets that are encoded by genes, but don't end up as proteins. In many cases, they have a role in down-regulating different cellular genes. In this case, a virus is engineered to be responsive to microRNAs that are present in certain cell types. Using this new form of targeting, researchers redirected a virus normally responsible for a lethal muscle infection to recognize only cancer cells. The laboratory mice that received the engineered virus were cured of established tumors and suffered no ill effects.
"Our findings demonstrate a new tool for molecular medicine that should also help allay concern over the use of viruses as a therapeutic delivery system," says Stephen Russell, M.D., Ph.D., Mayo physician-scientist and lead author of the study.
Significance of the research
Most viruses can infect different cell types, which leads to the array of symptoms during a viral infection. Now as viruses are being engineered for use as vaccines, cancer therapeutics and gene therapy vectors, researchers want to restrict and redirect the types of cells they do (or don't) infect as additional safeguards against disease. The target sequences of microRNAs used in the study kept the virus from destroying muscle cells while allowing viral replication to proceed in cancer cells allowing the virus to completely cure mice with melanoma.
The Mayo researchers say microRNA target insertion may be a new way to make viruses safer for use in cancer therapy and could lead to new methods of making safer vaccines.
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- Phase-Change Materials Set New Speed Limit For Silicon
- M60-UCD1: Tiny Galaxy, Supermassive Black Hole
- Life After The 125 GeV Higgs: What Is Left Of Two-Higgs Doublet Models
- Longer Telomeres And Genetic Determinant For Melanoma Risk
- Ig Nobel Prizes 2014: From Jesus On Toast To Baby Feces In Sausages
- Watching Neurons Learn: Learning New Ideas Is More Difficult
- Witness The Singularity AI Nanotech Co-Evolutionary Merger
- "Please re-read the first paragraph. It's missing an ending......"
- "If being very restrained brings you to write stuff as AFAIK he has never talked about the gaps..."
- "Hi Mephisto,we do have a similar problem to the one you mention in high-energy physics - when we..."
- "Concerning his political opinions, Lubos is a deluded annoying crank, but credit has to be given..."
- "Right on, and I have written articles on that issue in the past - by preventing uptake in wealthy..."
- Sharks more abundant on healthy coral reefs
- Using plants to produce enzyme may provide treatment for high blood pressure in lungs
- Lithium-sulfur batteries may mean a commercial reality with a bigger energy punch
- Small weight gain can raise blood pressure in healthy adults
- Environmentalists score a win, get government to control plastic bags